Two products under CHINARES PHARMA have been included in the national medical insurance catalog
CHINARES PHARMA (03320.HK) announced that its Yiqi Qingfei Granules and Methylphenidate Hydrochloride Sustained-Release Capsules have been included in the recently released "National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalog (2025)."
Yiqi Qingfei Granules are specifically aimed at the comprehensive symptoms during the recovery period of various respiratory infection diseases. Methylphenidate Hydrochloride Sustained-Release Capsules are used for the treatment of Attention Deficit Hyperactivity Disorder in children aged 6 and above. Both products were approved for market launch in January of this year
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments